Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05498493 · ClinicalTrials.gov registry record · NA
Cognitive Rehabilitation for Post-COVID-19 Cognitive Impairment
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT05498493 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 67 participants.
The verdict
NCT05498493, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
This pilot randomized controlled trial is to investigate the feasibility and efficacy of cognitive rehabilitation for patients with post-COVID-19 cognitive impairment. Additionally, the study will obtain preliminary data, using rsfMRI, regarding the potential underlying connectivity networks, mediating the effect of CR on cognitive improvements.
Interventions
- BEHAVIORAL Cognitive Rehabilitation
- BEHAVIORAL Brain Health Education Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2024-08-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05498493
The ClinicalTrials.gov registry entry for NCT05498493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Rehabilitation is the first listed.
NCT05498493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05498493 about?
NCT05498493 is a clinical study titled "Cognitive Rehabilitation for Post-COVID-19 Cognitive Impairment". This pilot randomized controlled trial is to investigate the feasibility and efficacy of cognitive rehabilitation for patients with post-COVID-19 cognitive impairment. Additionally, the study will obtain preliminary data, using rsfMRI, regarding the potential underlying connectivity networks, mediat...
What is the current status of trial NCT05498493?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2022-09-19. Estimated completion is 2024-08-20.
What interventions are being tested in trial NCT05498493?
The interventions under investigation include: Cognitive Rehabilitation (BEHAVIORAL), Brain Health Education Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05498493?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.